Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin

International Journal of Pharmaceutics

Volumn 464, Issue 1-2, 2014, Pages 127-134

  Termsarasab, Ubonvan ^a   Yoon, In Soo ^b   Park, Ju Hwan ^a   Moon, Hyun Tae ^a   Cho, Hyun Jong ^c   Kim, Dae Duk ^a  

^a Seoul National University   (South Korea)

^b Mokpo National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Arachidyl chitosan; Doxorubicin; Leukemia; Polyethylene glycol; Prolonged blood circulation

Indexed keywords

CHITOSAN DERIVATIVE; DOXORUBICIN; MACROGOL; NANOPARTICLE; POLYETHYLENE GLYCOL MODIFIED ARACHIDYL CHITOSAN BASED NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CELL STRAIN K 562; CONTROLLED STUDY; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG HALF LIFE; DRUG PROLONGED BLOOD CIRCULATION; DRUG SOLUBILITY; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA; MEAN RESIDENCE TIME; NONHUMAN; PH; PHARMACOLOGICAL PARAMETERS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STEADY STATE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ARACHIDYL CHITOSAN; DOXORUBICIN; LEUKEMIA; POLYETHYLENE GLYCOL; PROLONGED BLOOD CIRCULATION;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; DOXORUBICIN; DRUG CARRIERS; EICOSANOIC ACIDS; HUMANS; K562 CELLS; MALE; NANOPARTICLES; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84896716027     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.01.015     Document Type: Article

References (29)

1. Y. Bae, T.A. Diezi, A. Zhao, and G.S. Kwon Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents J. Control. Release 122 2007 324 330 (Pubitemid 47404677)
2. M.D. Chavanpatil, A. Khdair, and J. Panyam Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery J. Nanosci. Nanotechnol. 6 2006 2651 2663 (Pubitemid 44579937)
3. ® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
4. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Cho, J.H. Park, K. Kim, I.C. Kwon, and D.D. Kim Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis J. Control. Release 162 2012 111 118
5. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
6. C.W. Chung, K.D. Chung, Y.I. Jeong, and D.H. Kang 5-Aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy Int. J. Nanomedicine 8 2013 809 819
7. T.A. ElBayoumi, and V.P. Torchilin Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody Clin. Cancer Res. 15 2009 1973 1980
8. G. Gaucher, M.H. Dufresne, V.P. Sant, N. Kang, D. Maysinger, and J.C. Leroux Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 2005 169 188 (Pubitemid 41742123)
9. V. Jain, N.K. Swarnakar, P.R. Mishra, A. Verma, A. Kaul, A.K. Mishra, and N.K. Jain Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy Biomaterials 33 2012 7206 7220
10. Y.J. Jin, U. Termsarasab, S.H. Ko, J.S. Shim, S. Chong, S.J. Chung, C.K. Shim, H.J. Cho, and D.D. Kim Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma Pharm. Res. 29 2012 3443 3454
11. L.M. Kaminskas, D.B. Ascher, V.M. McLeod, M.J. Herold, C.P. Le, E.K. Sloan, and C.J. Porter PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases J. Control. Release 168 2013 200 208
12. L expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors Biochem. Pharmacol. 60 2000 1823 1828
13. S.J. Lee, H. Koo, H. Jeong, M.S. Huh, Y. Choi, S.Y. Jeong, Y. Byun, K. Choi, K. Kim, and I.C. Kwon Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy J. Control. Release 152 2011 21 29
14. Z. Liu, Y. Jiao, T. Wang, Y. Zhang, and W. Xue Interactions between solubilized polymer molecules and blood components J. Control. Release 160 2012 14 24
15. P.P. Lv, Y.F. Ma, R. Yu, H. Yue, D.Z. Ni, W. Wei, and G.H. Ma Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD) Mol. Pharm. 9 2012 1736 1747
16. C.F. Mu, P. Balakrishnan, F.D. Cui, Y.M. Yin, Y.B. Lee, H.G. Choi, C.S. Yong, S.J. Chung, C.K. Shim, and D.D. Kim The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel Biomaterials 31 2010 2371 2379
17. D.R. Nogueira, L. Tavano, M. Mitjans, L. Pérez, M.R. Infante, and M.P. Vinardell In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles Biomaterials 34 2013 2758 2772
18. N.V. Nukolova, H.S. Oberoi, S.M. Cohen, A.V. Kabanov, and T.K. Bronich Folate-decorated nanogels for targeted therapy of ovarian cancer Biomaterials 32 2011 5417 5426
19. D.E. Owens 3rd, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
20. G. Qu, Z. Yao, C. Zhang, X. Wu, and Q. Ping PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation Eur. J. Pharm. Sci. 37 2009 98 105
21. K. Rausch, A. Reuter, K. Fischer, and M. Schmidt Evaluation of nanoparticle aggregation in human blood serum Biomacromolecules 11 2010 2836 2839
22. U. Termsarasab, H.J. Cho, D.H. Kim, S. Chong, S.J. Chung, C.K. Shim, H.T. Moon, and D.D. Kim Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery Int. J. Pharm. 441 2013 373 380
23. U. Termsarasab, H.J. Cho, H.T. Moon, J.H. Park, I.S. Yoon, and D.D. Kim Self-assembled magnetic resonance imaging nanoprobes based on arachidyl chitosan for cancer diagnosis Colloids Surf. B: Biointerfaces 109 2013 280 286
24. F.M. Veronese, O. Schiavon, G. Pasut, R. Mendichi, L. Andersson, A. Tsirk, J. Ford, G. Wu, S. Kneller, J. Davies, and R. Duncan PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity Bioconjug. Chem. 16 2005 775 784 (Pubitemid 41026163)
25. Z. Xiao, E. Levy-Nissenbaum, F. Alexis, A. Lupták, B.A. Teply, J.M. Chan, J. Shi, E. Digga, J. Cheng, R. Langer, and O.C. Farokhzad Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection ACS Nano 6 2012 696 704
26. K.S. Yadav, S. Jacob, G. Sachdeva, K. Chuttani, A.K. Mishra, and K.K. Sawant Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia J. Microencapsul. 28 2011 729 742
27. T. Yang, M.K. Choi, F.D. Cui, J.S. Kim, S.J. Chung, C.K. Shim, and D.D. Kim Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome J. Control. Release 120 2007 169 177 (Pubitemid 47061489)
28. W. Zauner, M. Ogris, and E. Wagner Polylysine-based transfection systems utilizing receptor-mediated delivery Adv. Drug Deliv. Rev. 30 1998 97 113 (Pubitemid 28201908)
29. L. Zhang, Z.L. Zhao, X.H. Wei, and J.H. Liu Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles Int. J. Nanomedicine 8 2013 601 610